Barclays
MDWD icon

Barclays’s MediWound MDWD Stock Holding History

Barclays’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Sell
1,732
-302
-15% -$4.79K ﹤0.01% 4535
2026
Q1 		$32.8K Sell
2,034
-13,242
-87% -$230K ﹤0.01% 4449
2025
Q4 		$282K Buy
15,276
+3,747
+33% +$68.5K ﹤0.01% 4148
2025
Q3 		$208K Sell
11,529
-2,524
-18% -$46.5K ﹤0.01% 4269
2025
Q2 		$272K Buy
14,053
+3,926
+39% +$74K ﹤0.01% 4094
2025
Q1 		$157K Sell
10,127
-2,285
-18% -$40.9K ﹤0.01% 4173
2024
Q4 		$221K Buy
12,412
+1,249
+11% +$21.5K ﹤0.01% 4259
2024
Q3 		$202K Buy
11,163
+8,449
+311% +$154K ﹤0.01% 4277
2024
Q2 		$42.1K Buy
+2,714
New +$44.9K ﹤0.01% 4267
2022
Q2 		– Hold
0
– – – 5169
2022
Q1 		– Hold
0
– – – 5363
2021
Q4 		– Hold
0
– – – 4511
2021
Q3 		– Hold
0
– – – 4899
2021
Q2 		– Sell
-82
Closed -$3K – 4997
2021
Q1 		$3K Buy
+82
New +$2.97K ﹤0.01% 4531

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's MDWD Position: Q2 2026 in Review

Barclays reduced its MediWound (MDWD) stake by 15% in Q2 2026, selling an estimated $4.79K and leaving 1,732 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4535.

Barclays first reported a position in MDWD in Q1 2021 and has held it in 10 quarters since. The position peaked at $282K in Q4 2025. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Barclays held 1,732 shares of MediWound worth $25.5K as of Q2 2026.
  • Barclays sold 302 MediWound shares in Q2 2026, an estimated $4.79K.
  • MediWound made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4535 holding.
  • Barclays first reported a position in MediWound in Q1 2021 and has held it in 10 quarters since.
  • Barclays's MediWound position peaked at $282K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.